Skip to main content
. 2017 Aug 30;12(8):e0181242. doi: 10.1371/journal.pone.0181242

Fig 1. miRNA expression levels in serum from cervical cancer patients with local or metastatic disease.

Fig 1

Expression levels of four candidate miRNAs were determined via Taqman-based qPCR using RNA extracted from the serum of patients with local (n = 25) or metastatic (n = 24) cervical cancer. Serum expression levels of miR-23b-3p were significantly lower in the metastatic group (B; *p<0.05), while miR-944 expression was significantly higher in serum from patients with metastatic disease (D; **p<0.01). Serum expression levels of miR-23a-3p (A) and miR-193b-5p (C) were not significantly different between the local and metastatic groups.